Wang et al.24demonstrated the effects of MET in cancer, detailing that this drug inhibits abnormal cell proliferation by modifying the tumor microenvironment, which causes decreased angiogenesis, as well as by altering the tumor-associated macrophage phenotype that subsidises tumor development.24 This evidence concerns the gene MET and neoplasm.